Publications by authors named "Araz Sabzvari"

Claim this Profile
E
Efficacy and Safety of a Proposed Hyaluronic Acid (Lunaphil Ultra) Compared to the Reference Product (Juvéderm Ultra 4) for the Management of Moderate or Severe Nasolabial Folds: A Randomized, Double-Masked, Within-Subject, Equivalency-Controlled Trial.
Kamran Jazayeri, Omid Zargari, Hoshyar Gholami, Araz Sabzvari, Hamidreza Kafi

Aesthet Surg J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of clinical and safety outcomes of generic tacrolimus (Suprotac ®) versus branded tacrolimus (Prograf ®) in de novo liver transplant patients: a randomized clinical trial.
Mojtaba Shafiekhani, Mohammad Amin Jafarzadeh, Mohammad Ahmadi, Hamed Nikoupour, Alireza Shamsaeefar, Araz Sabzvari

Daru· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Tolerability Assessment of Deoxycholic Acid Injectable Solution for Reduction of Submental Fat Among the Iranian Population.
Taraneh Yazdanparast, Mansour Nassiri Kashani, Aniseh Samadi, Araz Sabzvari, Hamidreza Kafi

Aesthetic Plast Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Efficacy and Safety of Deoxycholic Acid Injection in Reduction of Flank Fat.
Navid Namakizadeh Esfahani, Faezeh Khorasanizadeh, Amirhoushang Ehsani, Maryam Nasimi, Hamidreza Mahmoudi, Araz Sabzvari

J Cosmet Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I.
Ali Rabbani, Mohammadreza Alaei, Samaneh Norouzi Asl, Aria Setoodeh, Marjan Shakiba, Araz Sabzvari

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of a "High and Low Molecular Weight Hyaluronic Acid Hybrid Complex" Injection for Face Rejuvenation.
Taraneh Yazdanparast, Azin Ayatollahi, Aniseh Samadi, Araz Sabzvari, Hamidreza Kafi

J Cosmet Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of efficacy and safety of generic tacrolimus (Suprotac) compared to reference tacrolimus (Prograf) in kidney transplantation: a phase IV study.
Behzad Einollahi, Mohsen Nafar, Mohammad Javanbakht, Amirhesam Alirezaei, Jalal Azmandian, Araz Sabzvari

Eur J Transl Myol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of a biosimilar somatropin (Cinnatropin®) in children and adolescents receiving growth hormone therapy over 1 year: a registry-based phase IV study.
Ali Rabbani, Maryam Razzaghy-Azar, Zohreh Karamizadeh, Mahin Hashemipour, Rahim Vakili, Araz Sabzvari

Eur J Pediatr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, two-armed, double-blind, single-dose, cross-over, bioequivalence clinical trial to compare pharmacokinetic parameters and safety of recombinant human factor VIII with Fc fusion produced by AryoGen Pharmed Company versus Elocta (reference product) in previously treated patients with severe haemophilia A.
Aziz Eghbali, Peyman Eshghi, Gholamreza Toogeh, Samin Alavi, Zahra Badiei, Araz Sabzvari

Ann Hematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY).
Vahid Shaygannejad, Fereshteh Ashtari, Morteza Saeidi, Nahid Beladi Moghadam, Hamidreza Ghalyanchi Langroodi, Araz Sabzvari

Mult Scler Relat Disord· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial.
Mohammad Ali Sahraian, Roya Abolfazli, Vahid Shaygannejad, Fereshteh Ashtari, Nastaran Majdinasab, Araz Sabzvari

Sci Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration.
Reza Karkhaneh, Hooshang Faghihi, Hamid Riazi-Esfahani, Mojtaba Abrishami, Fatemeh Bazvand, Araz Sabzvari

Ophthalmol Retina· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety evaluation of the trastuzumab biosimilar in Iranian women with HER2-positive breast cancer undergoing adjuvant chemotherapy: a post-marketing surveillance.
Fatemeh Zahedi, Anya Jafari, Behnam Nasiri Motlagh, Seyed Hassan Hamedi, Roham Salek, Araz Sabzvari

Expert Opin Drug Saf· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial.
Mostafa Ghanei, Babak Ghalebaghi, Ramin Sami, Mehdi Torabizadeh, Majid Mirsadraee, Araz Sabzvari

Front Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial.
Payam Tabarsi, Nassim Anjidani, Ramin Shahpari, Masoud Mardani, Araz Sabzvari

Clin Microbiol Infect· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations.
Payam Tabarsi, Nassim Anjidani, Ramin Shahpari, Masoud Mardani, Araz Sabzvari

Clin Microbiol Infect· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases.
S P Déo-Gracias Berry, Camille Dossou, Ali Kashif, Niusha Sharifinejad, Gholamreza Azizi, Araz Sabzvari

Int Immunopharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A  Phase IV Study of the Safety and Efficacy of CinnoPar in Iranian Patients with Osteoporosis.
Ahmadreza Jamshidi, Farhad Gharibdoost, Sima Sedighi, Asghar Hajiabbasi, Amir-Hossein Salari, Araz Sabzvari

J Osteoporos· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase I pharmacokinetic trial comparing the potential biosimilar adalimumab (CinnoRA®) with the reference product (Humira®) in healthy volunteers.
Ahmadreza Jamshidi, Araz Sabzvari, Nassim Anjidani, Ramin Shahpari, Nima Badri

Expert Opin Investig Drugs· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis